Charles Kuzma Selected Research

Charles Kuzma Research Topics

3	Neoplasms (Cancer) 01/2022 - 08/2017
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2024 - 12/2018
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2023 - 01/2021
1	Atrial Fibrillation 01/2024
1	Hypertension (High Blood Pressure) 01/2024
1	Triple Negative Breast Neoplasms 01/2022
1	Pathologic Complete Response 01/2022
1	Venous Thromboembolism 01/2020
1	Hemorrhage 01/2020
1	Disease Progression 12/2018
1	Splenomegaly 04/2003

2	Rituximab (Mabthera)FDA Link 04/2024 - 12/2018
2	Bendamustine Hydrochloride FDA Link 04/2024 - 12/2018
2	ibrutinibIBA 01/2024 - 12/2018
1	Bevacizumab (Avastin)FDA Link 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 01/2020
1	apixabanIBA 01/2020
1	Dalteparin (Dalteparin Sodium)FDA Link 01/2020

2	Radiotherapy 01/2023 - 01/2021
1	Neoadjuvant Therapy 01/2022
1	Ambulatory Care (Outpatient Care) 08/2017
1	Splenectomy 04/2003